Chemokine receptor CCR3 expression in malignant cutaneous tumors

Annals of Dermatology

Volumn 22, Issue 4, 2010, Pages 412-417

  Lee, Yoon Jin ^a   Kim, Dae Hyun ^a   Lee, Sang Han ^a   Nam, Hae Seon ^a   Roh, Mi Ryung ^b   Cho, Moon Kyun ^a  

^a Soonchunhyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cc chemokine receptors; CCR3; Chemokine

Indexed keywords

EID: 79955607725     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2010.22.4.412     Document Type: Article

References (25)

1. Shin JH, Cho SY, Whang KK, Hahm JH. An epidemiologic analysis of cutaneous malignant tumors over 15 years (1984 -1998). KoreanJ Dermatol 1999;37:1743-1751.
2. Seo PG, Moon SE, Cho KH. A statistical study of cutaneous malignant tumors (1996-2000). Korean J Dermatol 2002; 40:129-137.
3. Yoon TJ, Kim HS, Oh CW, Kim TH. A clinical investigation of cutaneous malignant tumors in western Gyeongnam province. Korean J Dermatol 1997;35:956-962.
4. Jeong KB, Kim HC, Shin DH, Choi JS, Kim KH. A clinical observation of cutaneous premalignant and malignant tumors. Korean J Dermatol 2002;40:924-931.
5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444.
6. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
7. Mantovani A. Cancer: inflaming metastasis. Nature 2009; 457:36-37.
8. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-550. (Pubitemid 38868623)
9. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270:27348-27357.
10. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998;188:373-386.
11. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-127.
12. Kleinhans M, Tun-Kyi A, Gilliet M, Kadin ME, Dummer R, Burg G, et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003; 101:1487-1493.
13. Jöhrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, et al. Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res 2005;11:2459-2465.
14. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1-17.
15. Schweickart VL, Epp A, Raport CJ, Gray PW. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines. J Biol Chem 2000;275:9550-9556.
16. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
17. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004;10:2351-2358.
18. Letsch A, Keilholz U, Schadendorf D, Assfalg G, Asemissen AM, Thiel E, et al. Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 2004;122: 685-690.
19. Simonetti O, Goteri G, Lucarini G, Filosa A, Pieramici T, Rubini C, et al. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. Eur J Cancer 2006;42:1181-1187.
20. Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 2003;198:1337-1347.
21. Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, et al. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. J Natl Cancer Inst 2008;100:502-512.
22. Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, et al. Growth regulated oncogenealpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000;19:3477-3486.
23. Miyagaki T, Sugaya M, Fujita H, Ohmatsu H, Kakinuma T, Kadono T, et al. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 2010;130:2304-2311.
24. Zlotnik A, Morales J, Hedrick JA. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 1999;19:1-47. (Pubitemid 29062100)
25. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002;99:4283-4297.